Abstract:Objective The association of high-sensivity C-reactive protein (hs-CRP) on patients undergoing percutaneous coronary intervention (PCI) and the long-term prognostic value were evaluated.Methods A prospective cohort study was prospectively conducted in 287 consecutive patients who were hospitalized in the Department of Cardiology of Shanghai Zhongshan Hospital undergoing primary PCI between Dec.2007 and Dec.2008.Levels of hs-CRP and other cardiovascular risk factors were determined before PCI.The patients were followed up for a mean of 54 months.Their cardiovascular end points were recorded.Results The mean value of serum hs-CRP in patients with cardiovascular disease (CVD) readmission and death was significantly higher than those without CVD readmission and death (2.21 mg/L versus 1.10 mg/L,Z=-3.152;6.60 mg/L versus 1.22 mg/L,Z=-3.192;P both ＜0.05).The cardiac troponin T,WBC,multivessel disease,stent placement and the low HDL-C are the factors relating to serum hs-CRP levels.The coefficients of correlation have statistical significance (t =8.575,4.763 and -2.770;P ＜0.05).The odd ratios for CVD readmissiom and CVD death were 1.714(95％ CI,1.164-2.523)and 5.023 (95 ％ CI,2.003-12.600).Kaplan-Meier survival analysis demonstrated a significantly reduced 5-year readmission rate in patients with 3.65 ＜ hs-CRP ≤ 82.51 mg/L [43.75％ (30/71) groups versus the lower hs-CRP level groups(20.83％,15/72) ; x2 =10.375,P ＜ 0.001by Log-rank].The same as the death rate [9.86％ (7/71) were evaluated in the lower hs-CRP level groups (1.38％,1/72) ;x2 =11.362,P ＜0.05 by Log-rank].The readmission rate and mortality in the patients with hs-CRP ＞3.0 mg/ L are 43.75％ (35/80)and 8.75％ (7/80),respectively.The survival time was all less than 20 months.Conclusions The results demonstrated that hs-CRP is an independent risk factor in cardiovascular disease.High hs-CRP is strongly associated with 5-year occurance of readmission and death for cardiovascular events.Hs-CRP can be a strong indicator of risk stratification and prognostic evaluation on cardiovascular high-risk populations.

Relationship between Inflammation Marker and Complication During Percutaneous Coronary Intervention and Ejection Fraction

Impact Of Increased Inflammation Biomarkers On Periprocedural Myocardial Infarction In Patients Undergoing Elective Percutaneous Coronary Intervention: A Cohort Study

Association of postprocedural neutrophil count and prognosis in ST-elevated myocardial infarction patients after percutaneous coronary intervention

Predictive Value of Baseline C-reactive Protein for Periprocedural Myocardial Infraction of Higher Risk Stratifications: A Retrospective Cohort Clinical Study

Association of postprocedural neutrophil count,ST-segment resolution and NT-proBNP in ST elevation myocardial infarction patients after percutaneous coronary intervention

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

Association of inflammatory markers based on routine blood with prognosis in patients underwent percutaneous coronary intervention

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Detection of Inflammatory Factors in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and their Relationships with Prognosis

The Value of Pre-Procedural Elevated NF-κB Activation in Predicting the Risk of Vascular Complications in Percutaneous Coronary Intervention

C-reactive Protein and Other Cardiovascular Biomarkers Are Prediction of Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention

Relationship Between Red Cell Distribution Width, High Sensitivity C-reactive Protein and Contrast-induced Nephropathy in Patients of Acute Coronary Syndrome With Percutaneous Coronary Intervention

Association between Multiple Inflammatory Biomarkers and Remnant Cholesterol Levels in Patients with Percutaneous Coronary Intervention: A Large-Scale Real-World Study

Predictive Value of Postprocedural Leukocyte Count on Myocardial Perfusion, Left Ventricular Function and Clinical Outcomes in ST-elevated Myocardial Infarction after Percutaneous Coronary Intervention.

The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction

Preoperative lymphocyte to C-reactive protein ratio: A new prognostic indicator of post-primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention